Recep Tayyip Erdoğan University
Rize, 53020, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07666126
Periodontitis is a multifactorial disease characterized by chronic inflammation of the gum tissue and alveolar bone destruction, and is known to be associated with various systemic diseases. Hyperuricemia, on the other hand, is a metabolic condition characterized by increased serum uric acid levels and can affect inflammation, oxidative stress, and bone metabolism. In recent years, the relationship between hyperuricemia and periodontal diseases has been increasingly investigated, but the biological mechanisms of this relationship have not yet been fully elucidated. Therefore, this study aimed to determine whether there is a relationship between hyperuricemia and periodontitis and to reveal the possible pathophysiological mechanisms of this relationship, which are shaped by inflammation, oxidative stress, and bone metabolism.
A total of 80 individuals aged 18-65 years will be included in this clinical observational study. The periodontal status of the participants will be assessed using clinical periodontal parameters such as probing pocket depth, clinical attachment loss, plaque index, gingival index, and bleeding on probing. Participants will be divided into four groups according to their periodontal status and the presence of hyperuricemia: individuals with periodontitis and hyperuricemia, individuals with periodontally healthy and hyperuricemia, individuals with periodontitis but without hyperuricemia, and individuals with periodontally healthy and without hyperuricemia. Gingival crevicular fluid and serum samples will be taken from the participants. In these samples, receptor-mediated nuclear factor kappa B ligand, osteoprotegerin, total antioxidant status, total oxidant status, oxidative stress index, interleukin-1 beta, interleukin-10, interleukin-18, and nucleotide-binding oligomerization domain-like receptor protein 3 levels will be analyzed. This study is considered unique because it examines the relationship between hyperuricemia and periodontitis by evaluating inflammation, oxidative stress, and bone metabolism parameters together.
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Rize, 53020, Turkey (Türkiye)
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Serum and GCF samples will be collected from participants in the first session
Periodontal clinical parameters will be measured from participants initially
Time frame: at baseline
The distance between the gingival margin and the base of the pocket will be measured in millimeters.
Time frame: at baseline
The distance between the enamel-cementum junction and the base of the pocket will be measured in millimeters.
Time frame: at baseline
Interleukin-1 beta levels will be determined from gingival crevicular fluid and serum samples using the ELISA method.
Time frame: at baseline
Interleukin-10 levels will be determined from gingival crevicular fluid and serum samples using the ELISA method.
Time frame: at baseline
Interleukin-18 levels will be determined from gingival crevicular fluid and serum samples using the ELISA method.
Contact information is provided by the study sponsor or research team.
Recep Tayyip Erdogan University Training and Research Hospital
Other
Evaluation of the Effect of Hyperuricemia on Alveolar Bone Loss and Oxidative Stress
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07536204
Gingival Diseases, Inflammation
Santiago, Metropolitan Region, Chile
View Trial DetailsNCT05533528
Alveolar Bone Loss, Bone Diseases
Murcia, Spain
View Trial DetailsNCT07254117
Alveolar Bone Loss, Bone Diseases
Riga, Latvia
View Trial DetailsNCT07146776
Alveolar Bone Loss, Bone Diseases
Istanbul, Üsküdar, Turkey (Türkiye)
View Trial Details